| NCT Number | NCT05832229 |
| Lead Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators: The Cleveland Clinic, Columbia University, Weill Medical College of Cornell University, Duke University, Mayo Clinic, University of Miami, University of Michigan, University of California, San Diego, University of California, San Francisco, LAC+USC Medical Center, Virginia Commonwealth University, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Cancer Institute (NCI), University of Southern California |
| Conditions | Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced, Cirrhosis Infectious, Cirrhosis Alcoholic, Cirrhosis Due to Hepatitis C |
| Enrollment | 256 participants |
| Start Date | 2023-12-07 |
| Primary Completion | 2029-08-31 (estimated) |
| Study Completion | 2029-08-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-02 |